Conquering epilepsies & brain disorders with courageous science
boldvision
Science-driven and patient-focused, our mission is to develop medicines that transform the lives of patients with epilepsies and seizure-related disorders.
boldscience
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders.
boldcommitment
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
press releases
- Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
- Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors
- Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting
- Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
boldpeople
Each team member understands the difference between a drug and a medicine—one is a product, the other changes lives—and that's what brings us together as Ovidians.